These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 21816376)

  • 1. CD39 expression on T lymphocytes correlates with severity of disease in patients with chronic lymphocytic leukemia.
    Pulte D; Furman RR; Broekman MJ; Drosopoulos JH; Ballard HS; Olson KE; Kizer JR; Marcus AJ
    Clin Lymphoma Myeloma Leuk; 2011 Aug; 11(4):367-72. PubMed ID: 21816376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia.
    Pulte D; Olson KE; Broekman MJ; Islam N; Ballard HS; Furman RR; Olson AE; Marcus AJ
    J Transl Med; 2007 May; 5():23. PubMed ID: 17480228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death.
    Serra S; Horenstein AL; Vaisitti T; Brusa D; Rossi D; Laurenti L; D'Arena G; Coscia M; Tripodo C; Inghirami G; Robson SC; Gaidano G; Malavasi F; Deaglio S
    Blood; 2011 Dec; 118(23):6141-52. PubMed ID: 21998208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells.
    Schuler PJ; Saze Z; Hong CS; Muller L; Gillespie DG; Cheng D; Harasymczuk M; Mandapathil M; Lang S; Jackson EK; Whiteside TL
    Clin Exp Immunol; 2014 Aug; 177(2):531-43. PubMed ID: 24749746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity.
    Häusler SF; Montalbán del Barrio I; Strohschein J; Chandran PA; Engel JB; Hönig A; Ossadnik M; Horn E; Fischer B; Krockenberger M; Heuer S; Seida AA; Junker M; Kneitz H; Kloor D; Klotz KN; Dietl J; Wischhusen J
    Cancer Immunol Immunother; 2011 Oct; 60(10):1405-18. PubMed ID: 21638125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypical analysis of ectoenzymes CD39/CD73 and adenosine receptor 2A in CD4
    Han L; Sugiyama H; Zhang Q; Yan K; Fang X; McCormick TS; Cooper KD; Huang Q
    Australas J Dermatol; 2018 Feb; 59(1):e31-e38. PubMed ID: 28295154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resident cardiac immune cells and expression of the ectonucleotidase enzymes CD39 and CD73 after ischemic injury.
    Bönner F; Borg N; Burghoff S; Schrader J
    PLoS One; 2012; 7(4):e34730. PubMed ID: 22514659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy between the ectoenzymes CD39 and CD73 contributes to adenosinergic immunosuppression in human malignant gliomas.
    Xu S; Shao QQ; Sun JT; Yang N; Xie Q; Wang DH; Huang QB; Huang B; Wang XY; Li XG; Qu X
    Neuro Oncol; 2013 Sep; 15(9):1160-72. PubMed ID: 23737488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased CD39 expression on CD4(+) T lymphocytes has clinical and prognostic significance in chronic lymphocytic leukemia.
    Perry C; Hazan-Halevy I; Kay S; Cipok M; Grisaru D; Deutsch V; Polliack A; Naparstek E; Herishanu Y
    Ann Hematol; 2012 Aug; 91(8):1271-9. PubMed ID: 22349724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reduced frequency of CD39
    Dong K; Wang Y; Yao Y; Yu W; Xu Z; Chen Y; Geng L; Wang S
    Int Immunopharmacol; 2024 Oct; 140():112743. PubMed ID: 39094356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered CD39 and CD73 Expression in Rheumatoid Arthritis: Implications for Disease Activity and Treatment Response.
    Ortiz MA; Diaz-Torné C; De Agustin JJ; Estrada P; Reina D; Hernandez MV; Sang H; Zamora C; Cantó E; Corominas H; Vidal S
    Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38275742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ectonucleoside triphosphate diphosphohydrolase-1 (E-NTPDase1/CD39) as a new prognostic marker in chronic lymphocytic leukemia.
    Abousamra NK; Salah El-Din M; Hamza Elzahaf E; Esmael ME
    Leuk Lymphoma; 2015 Jan; 56(1):113-9. PubMed ID: 24684231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of peripheral blood mononuclear cell isolation techniques and the impact of cryopreservation on human lymphocytes expressing CD39 and CD73.
    Turner RJ; Geraghty NJ; Williams JG; Ly D; Brungs D; Carolan MG; Guy TV; Watson D; de Leon JF; Sluyter R
    Purinergic Signal; 2020 Sep; 16(3):389-401. PubMed ID: 32754836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73
    Ahmadi P; Hartjen P; Kohsar M; Kummer S; Schmiedel S; Bockmann JH; Fathi A; Huber S; Haag F; Schulze Zur Wiesch J
    Cells; 2020 Jul; 9(8):. PubMed ID: 32707842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD73 and A2A receptors in cells from subjects with obesity and type 2 diabetes mellitus.
    Guzman-Flores JM; Cortez-Espinosa N; Cortés-Garcia JD; Vargas-Morales JM; Cataño-Cañizalez YG; Rodríguez-Rivera JG; Portales-Perez DP
    Immunobiology; 2015 Aug; 220(8):976-84. PubMed ID: 25770019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cells from Patients with Rheumatoid Arthritis Show Conserved CD39-Mediated Regulatory Function and increased CD39 Expression After Positive Response to Therapy.
    Zacca ER; Amezcua Vesely MC; Ferrero PV; Acosta CDV; Ponce NE; Bossio SN; Mussano E; Onetti L; Cadile I; Acosta Rodríguez EV; Montes CL; Gruppi A
    J Mol Biol; 2021 Jan; 433(1):166687. PubMed ID: 33098857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD39/CD73 and the imbalance of Th17 cells and regulatory T cells in allergic asthma.
    Wang LL; Tang HP; Shi GC; Wan HY; Tang W; Hou XX; Pan LN; Shi BY; Tao LQ
    Mol Med Rep; 2013 Nov; 8(5):1432-8. PubMed ID: 24065069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD73 is expressed by human regulatory T helper cells and suppresses proinflammatory cytokine production and Helicobacter felis-induced gastritis in mice.
    Alam MS; Kurtz CC; Rowlett RM; Reuter BK; Wiznerowicz E; Das S; Linden J; Crowe SE; Ernst PB
    J Infect Dis; 2009 Feb; 199(4):494-504. PubMed ID: 19281303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target tissue ectoenzyme CD39/CD73-expressing Foxp3+ regulatory T cells in patients with psoriasis.
    Zhang HY; Yan KX; Huang Q; Ma Y; Fang X; Han L
    Clin Exp Dermatol; 2015 Mar; 40(2):182-91. PubMed ID: 25284153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.